Efficacy and tolerability of vildagliptin as add‐on therapy to metformin in Chinese patients with type 2 diabetes mellitus
Changyu Pan(University of Auckland), J. Lu(Chinese PLA General Hospital), Xiaoyi Lv(Xinjiang University), Jianhua Ma(Sun Yat-sen University), S.X Zheng(Second Hospital of Tianjin Medical University), Ping Han(China Medical University), Jinhui Liu(Hunan Normal University), Xiaoping Xing(Chinese Academy of Medical Sciences & Peking Union Medical College), Giovanni Bader(Novartis (Switzerland))
Cited by 80
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Colon cancer diagnosis and staging classification based on machine learning and bioinformatics analysis
|Computers in Biology and Medicine|2022|183
Serum Raman spectroscopy combined with convolutional neural network for rapid diagnosis of HER2-positive and triple-negative breast cancer
|Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy|2022|156
Epidemiology of Type 2 Diabetic Foot Problems and Predictive Factors for Amputation in China
|The International Journal of Lower Extremity Wounds|2015|153